PatientSpotlight, by PanaceaIntelPatientSpotlight

Explained · Mental Health · 6 pieces

Explained

Plain-language primers - no jargon, no assumed background - for patients, caregivers, and anyone trying to understand what's actually going on.

FilterAll (75)Oncology (8)Rare Disease (8)Immunology (6)Neurology (22)Cardiometabolic (6)Respiratory (6)Women's Health (7)Mental Health (6)Ophthalmology (6)
These are written so a non-specialist can read them once and walk away with a working understanding. They are not medical advice. If you are new to the topic, the diagnosis primers are a useful place to start.

Diagnosis

2
ExplainedNEWMay 7, 2026

Autism spectrum disorder care explained

Plain-language primer on ASD care, why it is multidisciplinary, and what is changing in pharmacotherapy.

DiagnosisTreatmentPatient journey
ExplainedNEWMay 4, 2026

What is obsessive-compulsive disorder?

Plain-language primer on OCD, why it has multiple subtypes, and what therapy can offer.

DiagnosisTreatmentPatient journey

Treatment

3
ExplainedNEWMay 8, 2026

What is treatment-resistant schizophrenia?

Plain-language primer on treatment-resistant schizophrenia, why clozapine matters, and what comprehensive care looks like.

TreatmentPatient journeyInfrastructure
ExplainedNEWMay 5, 2026

What is tobacco use disorder?

Plain-language primer on tobacco use disorder, why quitting is difficult, and what the modern combined approach can offer.

TreatmentPatient journeyAccess
ExplainedApr 26, 2026FDA · peer-reviewed

How pediatric mental health prescribing differs from adult and why it matters

Pediatric mental health prescribing operates under different evidence frameworks, regulatory expectations, and access structures than adult prescribing. Understanding the differences is essential for any sponsor with mental health assets that are eligible for paediatric expansion or that interact with paediatric-eligible populations.

TreatmentDrug developmentRegulatory

Depression

1
ExplainedApr 26, 2026FDA · peer-reviewed · guideline-bodies

How depression staging is being formalised and what that means for trial design

The treatment-resistant depression (TRD) frame has been part of psychiatric research for decades, but the operational definitions have been inconsistent. A more formalised staging system is converging across regulatory, clinical, and trial frames, and the convergence has practical consequences for which patients enroll in which trial and which approvals follow.

DepressionTrdTrial designStaging